Advanced Nanocellulose-Based Materials: Production, Properties and Applications |
Autore | Vilela Carla |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (166 p.) |
Soggetto topico | Technology: general issues |
Soggetto non controllato |
bacterial nanocellulose
lignosulfonates mechanical performance thermal-oxidative stability ion-exchange membranes biobased separators ionic conductivity oxidized bacterial cellulose chitosan alginate layer-by-layer assembly multi-layered patches dexpanthenol wound healing cellulose nanocomposite ice-templating interface orientation mechanical properties cellulose nanofibrils wood lignin TEMPO-oxidation cellulose nanomaterials nanoscale resolution cellulose chitosan nanoparticles bionanocomposites 5-fluorouracil in vitro drug release cytotoxicity assay colorectal cancer lyophilization plasma modification cell adhesion cellulose nanocrystals folic acid fluorescein isothiocyanate nanosystems physical adsorption cellular uptake cellular exometabolomics folate receptor-positive cancer cells dissolving pulp cellulose nanofibril nano silicon dioxide high strength |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Advanced Nanocellulose-Based Materials |
Record Nr. | UNINA-9910557618003321 |
Vilela Carla
![]() |
||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Anticancer Agents : Design, Synthesis and Evaluation |
Autore | Chen Qiao-Hong |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (606 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
benzofurans
chemical synthesis cytotoxic properties HeLa MOLT-4 K562 anticancer anti-neuroinflammation coumarin dihydroartemisinin flavonoids allene E-stereoselective regioselective anti-cancer activity cyanopyridone substituted pyridine pyridotriazine pyrazolopyridine thioxotriazopyridine anticancer activity HepG2 antitumor activity computational docking MDM2-p53 interaction xanthones yeast-based assays estrone derivatives hydrazine N-substituted pyrazoline anti-ovarian cancer topoisomerase II inhibitor kinase inhibitor antiproliferative agent urea synthesis antiproliferative activity apoptosis indoleamine 2,3-dioxygenase inhibitor anti-tumor immune modulation tryptophan metabolism taxoids βIII-tubulin P-glycoprotein drug resistance thiopene thienopyrimidinone thiazolidinone breast cancer benzofuran–pyrazole nanoparticles cytotoxic activity PARP-1 inhibition 3,6-dibromocarbazole 5-bromoindole carbazole actin migration Thienopyrimidine Pyrazole PI3Kα inhibitor quinazolin-4(3H)-one quinazolin-4(3H)-thione Schiff base antioxidant activity DFT study ortho-quinones beta-lapachone tanshione IIA PI3Ks PI3Kδ inhibitors 2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide anticancer agents protein–protein interactions virtual screening mimetics drug discovery bivalency polyvalency antitumor cell cycle ovarian cancer P-MAPA IL-12 TLR signaling inflammation chemoresistance 4-(pyridin-4-yloxy)benzamide 1,2,3-triazole c-Met natural product anticancer agent zampanolide Talazoparib PARP inhibitor prodrug o-nitro-benzyl photoactivatable protecting groups salinomycin overcoming drug resistance tumor specificity synergy 5-fluorouracil gemcitabine amides/esters colchicine analogs thiocolchicine colchiceine antimitotic agents hydrates dihydropyranoindole HDAC inhibitors neuroblastoma aromatase MCF-7 NIH3T3 benzimidazole triazolothiadiazine docking ADME organosilicon compounds SILA-409 (Alis-409) SILA-421 (Alis-421) multidrug resistance (MDR) reversal ABCB1 (P-glycoprotein) colon cancer colchicine amide colchicine sulfonamide tubulin inhibitors docking studies crystal structure PROTACs protein degradation IGF-1R Src protein kinase phenylpyrazolopyrimidine enzyme inhibition molecular simulation androgen receptor prostate cancer enzalutamide apalutamide darolutamide triple-negative breast cancer cytotoxicity chrysin analogues flavonoid anticancer compounds |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Anticancer Agents |
Record Nr. | UNINA-9910557129103321 |
Chen Qiao-Hong
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Anticancer Drugs |
Autore | O’Boyle Niamh M |
Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
Descrizione fisica | 1 electronic resource (214 p.) |
Soggetto non controllato |
graphene oxide
indole androgens cyclooxygenase-2 cyclooxygenase-1 heteropolysaccharide drug conjugation drug delivery ellipticine chemical linker oesophageal cancer antiproliferative activity topoisomerase II ?-lactam DSD antibody topoisomerase inhibitors magnetic targeting cisplatin resistance steroidogenesis [18F]FDG PET/CT heterocyclic chemistry dehydroepiandrosterone antimitotic 3-vinylazetidin-2-ones glioblastoma and cancer therapy intestinal mucositis Combretastatin A-4 metabolism anti-cancer drugs maghemite COX-1 inhibitor anticancer CYP17A1 conjugate and hybrid drugs inflammation snticancer drugs P450c17 tumorigenesis cisplatin biomarker profiling cancer drug design tubulin cytochrome P450 5-fluorouracil prostate cancer abiraterone NCI screen radiation cancer immunotherapy microtubule targeted drugs cancer treatment resistance |
ISBN | 3-03921-587-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910367753903321 |
O’Boyle Niamh M
![]() |
||
MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Bioelectric Sensors |
Autore | Kintzios Spyridon E |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
Descrizione fisica | 1 electronic resource (114 p.) |
Soggetto topico | Technology: general issues |
Soggetto non controllato |
organic optoelectronic device
pulse meter biosensor Bluetooth low energy (BLE) photoplethysmogram (PPG) chronic wounds electrical stimulation direct microcurrent non-invasive pressure ulcer wireless technology biochips impedance spectroscopy electrical equivalent circuit biomaterial Lysinibacillus sphaericus JG-A12 anticancer therapeutic strategies apoptosis bioelectric 5-fluorouracil HeLa cell line superoxide cell immobilization 3D-printed well bioelectric profiling impedance analysis real-time measurements electrochemical biosensors SWCNT point-of-care diagnostics label-free biosensors ELISA carbon nanotubes bovine serum albumin pacemaker threat modeling internet of things (IoT) medical devices vulnerabilities |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557623103321 |
Kintzios Spyridon E
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Biopolymers in Drug Delivery and Regenerative Medicine |
Autore | García-González Carlos A |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (194 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
curcumin
pectin aerogels chitosan coating burst release controlled release Keratose drug-coated balloon paclitaxel drug delivery pre-clinical peripheral arterial disease endovascular cellulose phosphate cellulose phosphate aerogel interconnected porosity supercritical carbon dioxide tetrabutylammonium fluoride TBAF/DMSO polysaccharide κ-carrageenan dexamethasone electrochemical active deliver system doping agent charged molecule conductive polymers colorectal cancer antioxidants 5-fluorouracil polymer nanomaterials nanocapsules chemotherapy cryogel starch NMR spectroscopy morphology drug release polysaccharides hydrogels prilling droplets ionotropic gelation drying xerogels cryogels aerogels lipid microparticles PGSS® supercritical CO2 modeling solvent-free technology biomaterials porous materials biomimetic multi-stimulation tissue engineering |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557346803321 |
García-González Carlos A
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Pharmaceutical Residues in the Environment |
Autore | Kumirska Jolanta |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
Descrizione fisica | 1 electronic resource (292 p.) |
Soggetto topico |
Research & information: general
Environmental economics |
Soggetto non controllato |
ifosfamide
cyclophosphamide 5-fluorouracil cytostatic drug BDD anode electrochemical oxidation intermediates lincomycin monensin roxarsone migration residual toxicity pharmaceuticals endocrine disrupting compounds hydroponic cultivation determining target pollutants in plant materials municipal wastewater treatment plants ionic liquids green chemistry environmental and biological samples sample preparation determination of pharmaceuticals chromatographic methods electromigration techniques sulfamethoxazole antibiotic resistance genes sul genes bacterial community constructed wetlands environmental contaminants pharmaceuticals occurrence aquatic compartments soil poultry farms ultra-high performance liquid chromatography antibiotics, antibiotic resistance antibiotics wastewater sewage sludge risk assessment removal efficiency LC-MS/MS analysis Spirotox fluoxetine sertraline paroxetine mianserin pharmaceuticals in the environment wastewaters pharmaceutical residues conventional wastewater treatments solid phase extraction pharmaceuticals toxicity environmental risk assessment antibiotic resistance genes (ARGs) antibiotic-resistant bacteria (ARB) wastewater treatment plants (WWTPs) activated sludge (AS) constructed wetlands (CWs) environmental pollution spread of resistance tetracyclines sulfonamides fate in the environment fate in WWTPs ecotoxicity antibiotic resistance development of methods |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557113103321 |
Kumirska Jolanta
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Pharmacogenetics to Avoid Adverse Drug Reactions |
Autore | López-Fernández Luis A |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (220 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
5-fluorouracil
capecitabine fluoropyrimidine thymidylate synthase thymidylate synthase enhancer region upstream stimulatory factor 1 adverse drug reactions pharmacogenomics epistasis random forest statin cardiovascular disease colorectal cancer personalised medicine toxicity (es)citalopram drug-gene-interaction drug-drug-interaction drug-drug-gene-interaction the PharmLines initiative antipsychotic agents pharmacogenetics cytochrome P-450 enzyme system psychotic disorders precision medicine direct oral anticoagulants clinical implementation atorvastatin SLCO1B1 HLA cutaneous adverse drug reaction SCAR genetic polymorphism antiepileptics CYP450 enzymes platelet reactivity single-nucleotide variants acute coronary syndrome clopidogrel genotype allele polymorphism HLA B CYP2C9*3 cutaneous adverse drug reactions (CADRs) anti-epileptic drugs (AEDS) phenytoin (PHT) genetic risk factors South India India cardiology adverse events guidelines |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557610103321 |
López-Fernández Luis A
![]() |
||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Precision Medicine : Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy |
Autore | Turgeon Jacques |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (170 p.) |
Soggetto topico |
Medicine
Clinical & internal medicine |
Soggetto non controllato |
fibromyalgia (FM)
myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) microRNA miRNome pharmacogenomics pharmacoepigenomics SM2miR Pharmaco-miR repoDB ME/CFS Common Data Elements (CDEs) dihydropyrimidine dehydrogenase DPYD 5-fluorouracil fluoropyrimidine therapeutic drug monitoring orthotopic liver transplant busulfan glutathione S-transferase genetic polymorphism limited sampling strategy pharmacokinetics clinical pharmacogenetics pharmacogenetic testing adverse drug reactions genotype phenotype pharmacogene barriers to pharmacogenetics implementation Sub-Saharan Africa chronic low back pain (cLBP) genetics personalized treatment polymorphism CYP450 tacrolimus CYP3A5 liver transplant pharmacogenomic minority data collection drug biomarker pharmacogenetics pharmacogenetic test personalized medicine gene expression infliximab adalimumab ulcerative colitis Crohn disease inflammatory bowel disease |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Precision Medicine |
Record Nr. | UNINA-9910585940803321 |
Turgeon Jacques
![]() |
||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|